BridgeMD
New treatment option for Neuropathic Pain
Official title Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer
ClinicalTrials.gov ID: NCT05505188
What this study is testing
- What it's testing
- Head and neck cancers are a source of complications and after-effects related to the disease and treatment. These cancers and their treatment alter the quality of life of patients and generate pain with physical and psychological components.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with a first Head and neck cancer whose therapeutic sequence involves radiotherapy
- Patient over 18 years of age
- Having given written consent
- patient not previously treated with radiotherapy
- Life expectancy \> 3 months
You likely can't join if
- Non-consenting patient
- History of malignancy, other than treated and cured basal cell or cervical cancer
- Patient who has had a salvage surgery other than lymph node removal
- Patient with evidence of recurrence or other progressive neoplasia at the time of examination
- Patient who has had previous mutilating surgery (causing sequelae of swallowing and eating)
- Uncontrolled infectious pathology
See the full eligibility criteria
- Patients with a first Head and neck cancer whose therapeutic sequence involves radiotherapy
- Patient over 18 years of age
- Having given written consent
- patient not previously treated with radiotherapy
- Life expectancy \> 3 months
- World Health Organization (WHO) score \< 3
- Histologically proven Head and Neck cancer
- Stable patient, with no signs of recurrence or other progressive neoplasia at the time of the examination
- Patient treated with radiotherapy
- Patient fluent in French
- Non-consenting patient
- History of malignancy, other than treated and cured basal cell or cervical cancer
- Patient who has had a salvage surgery other than lymph node removal
- Patient with evidence of recurrence or other progressive neoplasia at the time of examination
- Patient who has had previous mutilating surgery (causing sequelae of swallowing and eating)
- Uncontrolled infectious pathology
- Patient under 18 years of age
- Patient who is not fluent in French
- Patient with a psychiatric pathology that could disrupt the study or prevent the interpretation of the results.
The study team makes the final eligibility decision.
Where it's taking place
- Caen, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caen, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.